Multimodal multiphasic pre-operative image-based deep-learning predicts hepatocellular carcinoma outcomes after curative surgery

Rex Wan Hin Hui, Keith Wan Hang Chiu, I. Cheng Lee, Chenlu Wang, Ho Ming Cheng, Jianliang Lu, Xianhua Mao, Sarah Yu, Lok Ka Lam, Lung Yi Mak, Tan To Cheung, Nam Hung Chia, Chin Cheung Cheung, Wai Kuen Kan, Tiffany Cho Lam Wong, Albert Chi Yan Chan, Yi Hsiang Huang, Man Fung Yuen, Philip Leung Ho Yu*, Wai Kay Seto*

*此作品的通信作者

研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)

摘要

Background Hepatocellular carcinoma (HCC) recurrence frequently occurs after curative surgery. Histological microvascular-invasion (MVI) predicts recurrence but cannot provide preoperative prognostication, whereas clinical prediction scores have variable performances. Methods Recurr-NET, a multimodal multiphasic residual-network random survival forest deep-learning model incorporating pre-operative CT and clinical parameters, was developed to predict HCC recurrence. Pre-operative triphasic CT scans were retrieved from patients with resected histology-confirmed HCC from four centers in Hong Kong (Internal-cohort). The internal cohort was randomly divided in an 8:2 ratio into training and internal-validation. External-testing was performed in an independent cohort from Taiwan. Results Among 1231 patients (Age 62.4, 83.1% male, 86.8% viral hepatitis, median follow-up 65.1 months), cumulative HCC recurrence at years 2 and 5 were 41.8% and 56.4% respectively. Recurr-NET achieved excellent accuracy in predicting recurrence from years 1-5 (Internal cohort AUROC 0.770-0.857; External AUROC 0.758-0.798), significantly out-performing MVI (Internal AUROC 0.518-0.590; External AUROC 0.557-0.615) and multiple clinical risk scores (ERASL-PRE, ERASL-POST, DFT, and Shim scores) (Internal AUROC 0.523-0.587, External AUROC: 0.524-0.620) respectively (all p<0.001). Recurr-NET was superior to MVI in stratifying recurrence risks at year 2 (Internal: 72.5% vs 50.0% in MVI; External: 65.3% vs 46.6% in MVI) and year 5 (Internal: 86.4% vs 62.5% in MVI; External: 81.4% vs 63.8% in MVI) (all p<0.001). Recurr-NET was also superior to MVI in stratifying liver-related and all-cause mortality (all p<0.001). The performance of Recurr-NET remained robust in subgroup analyses. Conclusion Recurr-NET accurately predicted HCC recurrence, out-performing MVI and clinical prediction scores respectively, highlighting its potential in pre-operative prognostication.

原文English
文章編號1180
期刊Hepatology
DOIs
出版狀態Accepted/In press - 2024

指紋

深入研究「Multimodal multiphasic pre-operative image-based deep-learning predicts hepatocellular carcinoma outcomes after curative surgery」主題。共同形成了獨特的指紋。

引用此